Table 3.
Whole Unisalkku dataset (N = 1989) | Training set (N = 1692) | Validation set (N = 99) | Primary test set (N = 198) | Embletta test set (N = 1959) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Number | Proportion | Number | Proportion | Number | Proportion | Number | Proportion | Number | Proportion | |
OSA severity | ||||||||||
No OSA | 967 | 48.6% | 827 | 48.9% | 50 | 48.5% | 90 | 45.5% | 905 | 46.2% |
Mild | 505 | 25.4% | 430 | 25.4% | 23 | 25.8% | 52 | 26.3% | 507 | 24.9% |
Moderate | 257 | 12.9% | 218 | 12.9% | 12 | 12.6% | 27 | 13.6% | 268 | 13.7% |
Severe | 260 | 13.1% | 217 | 12.8% | 14 | 13.1% | 29 | 14.6% | 279 | 14.2% |
Hypertension | 951 | 47.8% | 799 | 47.2% | 48 | 48.5% | 104 | 52.5% | — | — |
Diabetes | 399 | 20.1% | 330 | 19.5% | 20 | 20.2% | 49 | 24.7% | — | — |
Coronary artery disease | 247 | 12.4% | 204 | 12.1% | 13 | 13.1% | 30 | 15.1% | — | — |
A ‘—’ denotes that this data was not collected for the Embletta dataset.